Choice of human plasma preparations for transfusion
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 13 (2) , 84-88
- https://doi.org/10.1016/s0887-7963(99)80002-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Considerations of pool size in the manufacture of plasma derivativesTransfusion, 2003
- Current status of solvent/detergent‐treated frozen plasmaTransfusion, 1998
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Parvovirus B19 infection in patients with hemophiliaTransfusion, 1996
- Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 1995
- Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpuraBlood, 1994
- Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American PathologistsJAMA, 1994
- Transmission of Hepatitis A to Patients with Hemophilia by Factor VIII Concentrates Treated with Organic Solvent and Detergent To Inactivate VirusesAnnals of Internal Medicine, 1994
- Immune response to B19 parvovirus and an antibody defect in persistent viral infection.Journal of Clinical Investigation, 1989
- Diagnostic and pathogenetic considerations in transfusion‐related acute lung injuryTransfusion, 1985